Earnings webcast recording, slide presentation, and press release available at https://www.avient.com/investors/events-presentations. 1 Company’s non-GAAP reconciliation can be found at the press release here.

Earnings webcast recording, slide presentation and press release available at https://www.avient.com/investors/events-presentations. 1 Company’s non-GAAP reconciliation can be found at the press release here.

Earnings webcast recording, slide presentation and press release available at https://www.avient.com/investors/events-presentations. 1 Company’s non-GAAP reconciliation can be found at the press release here.

Like other Mevopur products, they are formulated with raw materials tested to ISO 10993-1 and USP , European Pharmacopeia 3.1.3 and 3.1.5, USP and ICH Q3D.   For more information, visit https://www.avient.com.      

NOTE TO EDITORS: Based on a multi-state HAI prevalence survey, the Centers for Disease Control and Prevention (CDC) reports that an estimated 722,000 HAIs per year occur in U.S acute care hospitals (source: http://www.cdc.gov/HAI/surveillance/). Media contact Sandy Wagner Marketing Communications Manager PolyOne GLS Thermoplastic Elastomers +1 815-759-2676 sandy.wagner@avient.com

The new formulation surpasses all specifications associated with the BS 7655-6.1:1997 standard, including the most stringent LTS 1 classification, even for complex designs and armored cables.   For more information, visit https://www.avient.com.  

For more information on PolyOne - Glasforms and GlasArmor ballistic resistant panels, visit https://www.polyone.com/products/advanced-composites. Michelle Maniscalco Senior Manager, Marketing Communications PolyOne Corporation +1 440-930-1988 michelle.maniscalco@avient.com

Polyone terms and conditions of sale France - updated September 2009 - 1 - PAI-376900v1 TERMS AND CONDITIONS OF SALE The Terms and Conditions herein apply to the sale of PolyOne products 1. Seller is entitled to rescind the sale agreement in the event that Buyer is in default of the purchase price payment by more than fifteen (15) days. In all events, Seller's liability with respect to default of delivery or untimely delivery shall not exceed 5 % of the invoice value of the deliveries, excluding any other claims.

AVNT-2022.06.30-News Release 1 NEWS RELEASE FOR IMMEDIATE RELEASE Avient Announces Second Quarter 2022 Results • Second quarter sales grew to $1.3 billion, a 5% increase over the prior year quarter, and an all-time quarterly record • GAAP EPS increased 24% to $0.92 compared to $0.74 in the prior year quarter • Adjusted EPS increased 13% to $0.98 compared to $0.87 in the prior year quarter, exceeding second quarter guidance of $0.92. https://www.avient.com/sustainability https://www.avient.com/investors https://edge.media-server.com/mmc/p/r2x4n7pt https://www.avient.com/investors https://register.vevent.com/register/BIb9438661fe984c4f9a842829169d2868 http://www.avient.com/investors/events-presentations 3 About Avient Avient Corporation (NYSE: AVNT), with 2021 revenues of $4.8 billion, provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. # # Investor Relations Contact: Giuseppe (Joe) Di Salvo Vice President, Treasurer and Investor Relations Avient Corporation +1 440-930-1921 giuseppe.disalvo@avient.com Media Contact: Kyle G.

Slide 1 PolyOne Corporation Page 0 PolyOne Investor Presentation Jefferies 2014 Global Industrials Conference New York, NY August 12, 2014 PolyOne Corporation Page 1 Forward-Looking Statements  In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 8 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 15.2% 12 – 16% Global Specialty Engineered Materials 1.1% 11.8% 12 – 16% Designed Structures & Solutions -- 7.1% 8 – 10% Performance Products & Solutions 5.5% 8.0% 9 – 12% Distribution 2.6% 6.0% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 66% 65 – 75% 3) ROIC* 5.0% 9.9% 15% 4) Adjusted EPS Growth N/A 40% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period (Est. in 2012) PolyOne Corporation Page 9 Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue CAGR PolyOne Corporation Page 10 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 11 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity* Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 *Pipeline as of May 29, 2014 as presented during our Innovation Day PolyOne Corporation Page 12 Healthcare Consumer Packaging and Additive Technology Transportation Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of June 30, 2014 Debt Maturities & Pension Funding – 6/30/14 Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of June 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 6/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.8 million shares in Q2 2014 Repurchased 8.2 million shares since early 2013 11.8 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?  Strong past performance demonstrates that our strategy and execution are working  Megatrends and emerging opportunities align with our strengths  Innovation and services provide differentiation, incremental pricing power, and competitive advantage  Strong and proven management team driving growth and performance  Addressable market exceeds $40 billion 1 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S.